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Abstract
Chemokines are extracellular mediators of complex regulatory circuits involved principally in cell-to-cell communication.
Most studies to date of the essential chemokine Cxcl12 (Sdf-1) have focused on the ubiquitously expressed secreted
isoforms a and b. Here we show that, unlike these isoforms and all other known chemokines, the alternatively transcribed c
isoform is an intracellular protein that localizes to the nucleolus in differentiated mouse Cardiac tissue. Our results
demonstrate that nucleolar transportation is encoded by a nucleolar-localization signal in the unique carboxy-terminal
region of Sdf-1c, and is competent both in vivo and in vitro. The molecular mechanism underlying these unusual chemokine
properties involves cardiac-specific transcription of an mRNA containing a unique short-leader sequence lacking the signal
peptide and translation from a non-canonical CUG codon. Our results provide an example of genome economy even for
essential and highly conserved genes such as Cxcl12, and suggest that chemokines can exert tissue specific functions
unrelated to cell-to-cell communication.
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Introduction
Chemoattractant cytokines, known as chemokines, are a class of
small proteins that play key roles in intercellular signalling and cell
migration throughout animal development and duringadult life [1].
The chemokine Cxcl12, also known as stromal cell-derived factor 1
(Sdf-1) is a member of the CXC chemokine family, and is
responsible for a variety of processes central to homeostasis and
physiology [2,3,4] through binding to the seven transmembrane
domain, G-protein coupled family of receptors (GPCR) Cxcr4 [5]
and Cxcr7 [6]. Cxcr4 intracellular responses to Cxcl12/Sdf-1
involve signal transduction via PI3K, PLC/PKC, and MAPKp24/
44 (ERK1/2), stimulating pathways associated with cell survival,
whereas recent findings in zebrafish suggest that Cxcr7 functions
primarily by sequestering Cxc12. CxcR7 heterodimerizes with
CxcR4 and regulates Cxcl12-mediated G protein signaling [7]
Gene deletion of Cxcl12, Cxcr4 or Cxcr7 results in embryonic
lethality from E18.5 and is associated with severe developmental
defects affecting the central nervous system, heart and vasculature
[8,9,10,11]. Three isoforms of Cxcl12/Sdf-1, produced from
alternatively spliced mRNA variants, have been identified in
humans, rats and mice [12,13,14]. Sdf-1a and b were the first
isoforms identified, and most available data on Sdf-1 were
obtained with the a isoform. These isoforms are highly similar,
distinguished by a difference in just four amino acids in the C-
terminus and a larger 39UTR in Sdf-1b. This similarity is reflected
in the minor differences between their biological properties [12].
Both proteins are secreted via the canonical intracellular secretory
pathway, mediated by a signal peptide sequence.
The c isoform was identified more recently, together with other
minor isoforms in humans (d, e, and w) [13]. Preliminary data
from humans show that SDF-1c expression is mainly restricted to
regions of adult brain and heart, with a similar pattern seen in rats
[14,15]. However, the biological significance of Sdf-1c has been
unclear, since it binds Cxcr4 with low affinity and displaces Cxcr4-
bound Sdf-1a only at high concentrations [16]. Moreover, it is
ineffective at driving signal transduction, as revealed by its low
capacity to stimulate intracellular calcium mobilization, weak
chemotactic activity and lack of effect on progenitor cell survival
[17]. Contrasting with the sequence similarity of Sdf-1a and b,
Sdf-1c contains a unique thirty amino-acid sequence at its C
terminus, making it almost twice as large as Sdf-1a and b (14
versus 8 kDa) [18]. Moreover, almost 60% of the residues in this
C-terminal extension are basic (lysine and arginine). Enrichment
in basic residues is a characteristic of protein domains involved in
intermolecular interactions with DNA, lipids, sugars and other
proteins, and in translocation across membranes during localiza-
tion to subcellular compartments. The lysine and arginine residues
in the Sdf-1c C-terminal region are arrayed in at least four clusters
resembling the canonical nuclear localization signals (NLS) of
cellular and viral proteins [19], a feature not described for any
other chemokine. Recent reports describe extracellular actions for
two of these clusters as heparan-sulphate binding domains, with
unexpectedly strong binding affinity for cellular glycosaminogly-
cans (GAGs) [16,20]. However, all these experiments were
conducted with in vitro synthesized recombinant Sdf-1c, and
activity derived from the expression from the endogenous locus
has not been reported.
PLoS ONE | www.plosone.org 1 October 2009 | Volume 4 | Issue 10 | e7570Here, we demonstrate that Sdf-1c is a nuclear protein in the
mouse heart, where it is expressed in a temporally coordinated
pattern during development and at high levels postnatally and in
adults. Our results show that the Sdf-1c C-terminal region localizes
the protein to the nucleus via canonical NLS motifs and to the
nucleolus via a specific nucleolar localization signal (NoLS). The
Sdf-1c C-terminal extension moreover confers nuclear localization
on heterologous cytoplasmic proteins. We have demonstrated that
the Sdf-1c mRNA in cardiac tissue has a short (25 nt) leader
sequence which lacks a signal peptide sequence and the AUG
initiation codon used to translate Sdf-1a and b mRNAs. Sdf-1c is
instead translated from the non-canonical codon CUG at position
169. These findings establish Sdf-1c in a different class from all
known chemokines, as a member of the nuclear proteome [21], and
introduce the novel idea that chemokines can exert intracellular
signalling functions not directly related to intercellular signalling.
Results
Sdf-1c is predominantly expressed in the heart in mice
Published data on the human and murine expression patterns of
Sdf-1 family members are scarce, and do not provide systematic,
quantified or sufficiently detailed information [13,18,20,22]. We
investigated the expression patterns of Sdf-1a, b and c mRNAs
during mouse development to gain insight into possible isoform
specificity. For this, we designed primers to target exons specific to
each alternately-spliced isoform (Fig. S1), and used these to probe
total RNA by qRT-PCR. For embryos, RNA was extracted from
liver, heart, aorta–gonad–mesonephros (AGM) and yolk sac at
stages E14.5, E15.5, E16.5 and E18.5. For later stages, RNA was
extracted from liver, heart, brain, and bone marrow of newborns
(P0) and adults (3-months old). Expression of Sdf-1a did not vary
significantly between organs or with developmental stage, whereas
Sdf-1b and Sdf-1c did (Fig. 1A). For comparisons, the expression of
Sdf-1a at E14.5withineach tissue wassetasthe baseline. Expression
of Sdf-1c increased from E15.5, becoming the most abundant Sdf-1
transcript at E18.5 in the developing heart, AGM and yolk sac.
Sdf1bisthe mainisoformexpressedinliver,withSdf-1c and abarely
detectable at all times studied. Expression of Sdf-1c mRNA
increased throughout development, reaching a maximum at birth.
Adult mice (3 months) showed a marked tissue-specific
expression of Sdf-1 isoforms. Sdf-1b expression is prominent in
hematopoietic tissues (bone marrow) and liver. In contrast, Sdf-1c
is abundant in brain and especially in heart: Sdf-1c mRNA levels
in these organs were respectively ,27-fold and ,260-fold above
those of Sdf-1a (Fig. 1B). These findings support the idea that Sdf-
1c can be considered a predominantly cardiac version of the
chemokine Cxcl12.
Sdf-1c localizes to the nucleus of cardiomyocytes
To examine protein expression of Sdf-1c in heart by
immunohistochemistry, a specific anti-Sdf-1c antibody (hereafter
called anti-c) was raised in rabbit against a peptide sequence from
the Sdf-1c carboxy-terminal end (Fig. S2) and affinity purified
before use. Antibody specificity and reactivity were analyzed by
Western blot of extracts of HEK293T cells transfected with
constructs pSdf1a-30–359 or pSdf1c-30–450, encoding the alpha
and gamma isoforms, respectively (Fig. S2). The anti-c antiserum
is specific for Sdf-1c, recognizing the same protein as the pan anti-
Sdf-1 monoclonal MAB350 in cells over expressing Sdf1c. Anti-c
showed no cross-reactivity with cellular proteins (Fig. S2). Thin
sections of heart tissue were labelled to detect Sdf-1c (anti-c or
MAB350), endothelial cells (anti-CD31) and myocardial cells (anti-
troponin a). Both MAB350 (Fig. 1C) and anti-c (Fig. 1D–F)
labelled with comparable specificity a heart protein that was
abundant in CD31+ endothelial cells lining the endocardium and
in troponin a positive myocardial cells (Fig. 1C, E; arrowheads in
insets). Single-cell resolution confocal immunofluorescence with
both anti-Sdf-1 antibodies revealed a strong nuclear signal in
troponin-a positive cells (Fig. 1C, E enlarged), and also in a
fraction of endothelial cells, identified by localization and
morphological criteria (Fig. 1C; asterisk in enlarged image), and
all along the cardiac parenchyma (Fig. 1D). Furthermore, a
punctate staining pattern typical of nucleolar localization (Fig. 1C–
F) was observed in a significant proportion of cells with nuclear
Sdf-1c staining, suggesting targeting to the nucleolus.
Nuclear targeting of Sdf-1c maps to the specific
carboxy-terminus
In silico sequence analysis of the SDF-1c C-terminus identified a
region enriched in basic amino acids (Lys and Arg) that shows high
homology with classical NLS motifs of both the SV40 and
bipartite nucleoplasm-like types (Fig. 2A) [19]. For ease of
description, we have arranged the Lys and Arg residues into four
clusters, numbered 1 through 4. To assess Sdf-1c subcellular
localization in detail, we ectopically expressed full-length Sdf-1c in
vitro. Plasmid pSdf1c–30–450 contains a cDNA sequence
corresponding to Sdf-1c mRNA from brain according to annotated
data (NM_001012477) (Fig. S1). Sdf-1c was localized to the nuclei
of almost 90% of transfected HEK293T cells, regardless of the
antibody used (Fig. 2B). There was no evidence of Golgi
accumulation of Sdf-1c, in contrast to ectopically expressed Sdf-
1a (Fig. 2B). To confirm nucleolar localization of Sdf-1c,w e
transfected HEK293T cells with the pSdf1c 96–450eGFP
(encoding a C-terminal fusion of Sdf-1c with eGFP; Fig. S1),
and immunostained these cells for Sdf-1c and fibrillarin, a
nucleolar marker. Both proteins co-localized to the nucleolus,
although Sdf-1c mapped to the granular component, excluded
from the fibrillar component labelled by fibrillarin.
To examine whether the nuclear localization signal for Sdf-1c is
located in the basic C-terminus, we fused the unique fourth exon
encoding this region to the carboxyl end of cerulean fluorescent
protein(CFP,pCFPSdf1c–360–450).InHEK293Tcellstransfected
withthisplasmid the localization of CFPwasunequivocally nuclear,
with sub-localization to the nucleoli, and the same distribution was
seen with CFP fused to full-length Sdf-1c (pCFPSdf1c2962450)
(Fig. 2C). The exon-4-encoded Sdf-1c C-terminus is thus sufficient
for nuclear localization, a finding confirmed by the fact that Sdf-1a
and b, functionally equivalent to Sdf-1c deletion mutants for this
region, do not localize to the nucleus.
The contribution of each basic amino-acid cluster to Sdf-1c
nuclear localization was explored with mutant versions of
pCFPSdf1c–360–450 in which Lys and Arg residues were
substituted by Ala, in accordance with natural mutation rates
[23]. Construct pCFPW contains substitutions of all four clusters of
basic residues; pCFP2 contains substitutions of clusters 1, 3 and 4;
pCFP14 of clusters 2 and 3, and pCFP124 of cluster 3. Un-
mutated pCFPSdf1c–360–450 is represented here as pCFP1234.
When expressed in HEK293T cells, un-fused CFP and CFPW
distributed evenly throughout the cell, with no organelle-specific
localization (Fig. 2D), discounting any significant role for passive
diffusion in the redistribution of the low molecular weight Sdf-1c.
In contrast, CFP2 localized evenly throughout cell nuclei,
indicating that cluster 2 (KKKR), which resembles the SV40-type
NLS, is sufficient for nuclear redistribution. CFP14, maintaining
integrity of clusters 1 (KKEK) and 4 (KRK), targeted the nucleus
in the absence of cluster 2, but a proportion of transfected cells
showed a cytoplasmic distribution. CFP124 was extensively sub-
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PLoS ONE | www.plosone.org 2 October 2009 | Volume 4 | Issue 10 | e7570Figure 1. Isoform c is the predominant Sdf-1 isoform expressed in the postnatal mouse heart. (A) mRNA expression of the main Sdf-1
isoforms during late embryonic development and postnatally. Expression levels of Sdf-1a, Sdf-1b and Sdf-1c were measured by quantitative real-time
PCR on total RNA extracted from the indicated tissues at the indicated times. For each tissue, mRNA amounts were normalized to Sdf-1a expression at
E14.5 (=1). AGM: aorta–gonad–mesonephros (B) Comparison of Sdf-1 isoform mRNA expression in adult (P90) tissues (qRT-PCR). RNA amounts in
each tissue were normalized to Sdf-1a expression (=1). For embryo samples, RNA was pooled from at least five littermates; for postnatal stages,
samples from five age-matched individuals at P0 or P90 were pooled. Analysis at each stage was repeated three times, yielding similar results (n=5).
(C to F) Confocal immunofluorescence of cardiac expression of Sdf-1c in adult mice (P90). Thin (5 mm) cryosections of three-month old mouse heart
were stained for Sdf-1 (red) with anti-pan Sdf-1 antibody (MAB350; C) or specific anti Sdf-1c antibody (anti-c; D,E,F). Green staining shows
immunofluorescence of troponin T alpha (C, E) or CD31 (F). Nuclei were stained with DAPI (blue). Lower panels show high-magnification images of
the boxed areas in the upper panels. Nuclear staining with anti-Sdf-1 antibodies is indicated by arrowheads (non-endothelial cells) or asterisks
(endothelial cells). Note the nucleolar staining with anti-Sdf-1 antibodies, seen as spots inside nuclei.
doi:10.1371/journal.pone.0007570.g001
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sequence (CFP1234) (Fig. 2D). However, detailed observation of
CFP1234 revealed localization to the granular component of
nucleoli, in agreement with data obtained by co-labelling for
fibrillarin (Fig. 2B right). This result indicates that exclusively
nucleolar localization requires the presence of all four clusters, and
based on this we can identify the putative NoLS as KKE-
KIGKKKRQKKRKAAQKRK.
These results were further confirmed by analysis of Sdf-1c
distribution in subcellular compartments (cytoplasm, nucleolus and
nucleoplasm) in transfected HEK293T cells. Western blot of
fractionated cultures revealed that the protein is expressed as two
reactive species with apparent molecular weights of 12 and 14 KDa
onpolyacrylamidegels,representinglargerproductsthanSdf-1a/b.
Importantly, Sdf-1c mostly accumulates in the nucleolar fraction
and is almost completely excluded from the cytosol (Fig. 2E).
Sdf-1c is translated from a short mRNA expressed in
cardiac tissue that skips the signal peptide encoded in
the first exon
The published sequence for Sdf-1c mRNA cloned from brain
indicates that the translated protein should contain an N-terminal
signal peptide, like Sdf-1a and b, together with the specific basic C-
terminal end. To assess whether the exposed N-terminal signal
peptide interferes with Sdf-1c nucleolar localization, we ectopically
expressed Sdf-1c proteins labelled C-terminally with the cytoplas-
mic antigen V5. HEK293T cells transfected with pSdf1c230–
450V5, encoding full-length Sdf-1c, showed a diffuse immunoflu-
orescence signal for V5, with accumulation in the perinuclear space
but not in any structure resembling the Golgi apparatus (Fig. 3A). In
contrast, an N-terminal deletion Sdf-1c mutant lacking the signal
peptide (encoded by pSdf1c2151–450V5) predominantly localized
to the nucleus in most transfected cells (Fig. 3A). These findings
suggest that the opposing actions of the signal peptide and NoLS
conflict when present in the same protein.
We next investigated whether Sdf-1c transcription is subject to
any process that counteracts the negative action of the signal
peptide on nuclear accumulation. For this, we compared the Sdf-1c
mRNA species transcribed in adult brain and heart tissues which
express high amounts of Sdf-1c mRNA (Fig. 1A). RACE nested
PCR assays were performed to identify transcription initiation sites,
and the results compared with the Sdf-1 species transcribed in liver.
Figure 2. The Sdf-1c carboxy-terminal region contains a
nucleolar localization signal. (A) Schematic of the Sdf-1 locus
showing the predicted Sdf-1c exon structure, based on the annotated
Sdf-1c mRNA sequence from brain, and detail of the unique Sdf-1c C-
terminal exon 4. Basic amino-acid residues (Arg/Lys) are shown bold, and
clusters of basic residues are boxed and numbered. SV40 and
nucleoplasmin NLS sequences are shown for comparison. (B) Left
panel. Confocal immunofluorescence of HEK293T cells transfected with
plasmids pSdf1c–30–450 (Sdf-1c) and pSdf1a–30–450 (Sdf-1a). Subcel-
lular localization of overexpressed Sdf-1 proteins (red) was detected with
pan anti-Sdf-1 (MAB350) or specific anti-Sdf-1c (anti-c). Right panel.C o -
labeling of the nucleolar protein fibrillarin and pSdf-1c by confocal
immunofluorescence. HEK293T cells were transfected with plasmid
pSdf1c–30–450 and immunostained for fibrillarin and Sdf-1c. Individual
and merged images of a representative field are shown on the left, and
the inset regions are shown at high magnification on the right to show
the localization of Sdf-1c (green) and fibrillarin (red) in granular and
fibrilar nucleololar regions, respectively. In both panels nuclei are stained
with DAPI (blue). (C) Fluorescence images of HEK293T cells transfected
with the indicated plasmids encoding cerulean fluorescent protein (CFP)
fused to full-length Sdf-1c (left) or the Sdf-1c specific carboxy-terminus
(center); The right panel shows results with unfused CFP. CFP
fluorescence is shown blue, and nuclei are stained with TOPRO-3 (red).
(D) Fluorescence images of HEK293T cells transfected with CFP fusions of
wild-type or mutated versions of the Sdf-1c C-terminal domain.
Unmutated clusters of basic residues are colored as in A, and mutation
(Lys/ArgRAla) of the clusters is shown by the white/crossed boxes.
Fluorescence signals are as in (C). Arrowheads indicate nucleoli. (E)
Western blot of subcellular fractions of cell extracts. Cell equivalents were
loaded on each lane. T, whole cell extract; C, cytoplasm; Np, nucleoplasm;
No,nucleoli.Sdf-1cwas stainedwithanti-canddevelopedwithHRP-goat
anti rabbit secondary antibody.
doi:10.1371/journal.pone.0007570.g002
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in Fig. 3B) in combination with specific reverse primers (coloured
arrowheads) allowed us to specificallyamplify Sdf-1c mRNA (red) or
a sequence common to all three isoforms (green). The major Sdf-1c
product amplified from brain was the predicted 450 bp sequence,
but in heart a single band of about 250 bp was amplified. No Sdf-1c
band was amplified from liver, confirming lack of expression in this
tissue. Sequencing revealed that the start site of the heart-specific
Sdf-1c transcript locates to nucleotide +145 downstream of the start
site used for Sdf-1a/b (Fig. 3B). Interestingly, the cardiac Sdf-1c
transcripts lack the sequence encoding the signal peptide; this heart-
specific transcript thus skips the AUG translation start codon used
by Sdf-1a/b, present at the beginning of exon 1 (orange box in
scheme in Fig. 3B). The Sdf-1c transcript amplified in brain starts as
predicted from the annotated +1 start site used for Sdf-1a/b.
Use of nested PCR with reverse primers directed to exon 3,
common to all three isoforms (green arrowhead in Fig. 3B),
identified a 330 bp product corresponding to transcription from the
+1 start site in heart, brain and liver; however, the main product
amplified in heart was a shorter band (190 bp), which sequencing
showed to correspond to transcription of Sdf-1c from the +145 start
site. This finding is consistent with the expression of two proteins in
different relative proportions revealed by Western blot (Fig. 2E).
These data indicate that nuclear expression of Sdf-1c in the heart is
achieved by transcription of an mRNA with a shortened leader
sequence (slmRNA) which omits the signal peptide.
Translation of nuclear-targeted Sdf-1c initiates from a
non-canonical CUG initiation codon
The absence of an AUG initiation codon from the slmRNA
suggests an alternative mode of translation initiation for nuclear-
targeted Sdf-1c. To assess first whether the slmRNA transcript
supports translation of Sdf-1c, we transfected HEK293T cells with
pcDNA-Sdf1c-145–450, which contains the cDNA of slRNA
sequence (starting from +145, a/b numerals). Immunostaining
with anti-c and MAB350 antibodies confirmed high expression of
the transfected protein and detected localization of the immuno-
reactive protein in the nucleolar compartment in the majority of
transfected cells (Fig. 4B).
Non-canonical initiation codons have been described in a
variety of proteins, and CUG seems to be the most common in
metazoans [24]. Sequencing of a cDNA corresponding to slmRNA
(Fig. 4A) indicated the presence of several in-frame CUG codons
that are compatible with the synthesis of a 12 kDa protein (Fig. 2E).
To determine which of the CUG codons is used we constructed a
series of C-terminally eGFP-tagged expression plasmids derived
from pcDNA-Sdf1c-145–450, in each of which a single CUG
codon is mutated to CUA, which does not function as an initiation
codon [25] (Fig. 4A). As a control, pcDNASdf1c-145–450,
encoding the whole cDNA obtained from slmRNA, was also
assayed. When transfected into HEK293T cells, the mutations at
position 232 (M3 in Fig. 4C) and 280 (M4) did not affect the
expression of Sdf-1c-eGFP (Fig. 4C), whereas the 169CUG
mutation did (M2 in Fig. 4C). Thus CUG 169 is necessary for
translation, suggesting that it is the non-canonical initiation codon
used to translate Sdf-1c from slmRNA in the heart.
Sdf-1c nucleolar localization is unrelated to degradation
Nuclear localization is a feature of protein degradation via the
nuclear ubiquitin-proteasome system (nUPS), and inhibition of this
pathway increases accumulation of proteins targeted for degrada-
tion [26]. Sdf-1c accumulation in nucleoli of transfected cells
might therefore be linked to nUPS-mediated degradation, perhaps
as a regulatory or quality control mechanism. To test this, we
transfected HEK293T cells with pcDNASdf1c-145–450, and
treated them with MG132, an inhibitor of the proteasome ligase
system. Nucleolar accumulation of Sdf-1c was not increased by the
treatment (Fig. S3), indicating that the Sdf-1c turnover is not
affected by proteasome activity and therefore that it localizes to the
cell nucleoli through an active mechanism.
Discussion
The findings presented here show that the major Sdf-1/Cxcl12
transcript (slmRNA) encoding the c isoform in cardiac tissue is
translated from the non-canonical initiation codon CUG formed at
the junction of exons 1 and 2. The chemokine is therefore expressed
Figure 3. Expression of a specific Sdf-1c mRNA in heart skips
translation of the signal peptide. (A) Confocal immunofluores-
cence of C-terminally V5-tagged Sdf-1c proteins. HEK293T cells were
transfected with Sdf-1c constructs including (left) or omitting (right) the
N-terminal signal peptide sequence. Over expressed Sdf-1c was
detected with anti-V5 antibody (red). Nuclei were stained with DAPI
(blue). (B)5 9 RACE was carried out on mRNA from adult mouse heart
(H), brain (B) and liver (L), and cDNA products were amplified by nested
PCR. The schematic represents the published annotated exon
composition of Sdf-1a/b mRNA and Sdf-1c, including exon 4. The
predicted sizes of PCR products for mRNAs initiated at +1 are shown
underneath. The positions of the RACE primers are shown by the small
arrows 1–3, and the positions of corresponding PCR primers are shown
by the coloured triangles. The gels show the actual products detected
with the shared primer (green) and the c-specific primer (red).
doi:10.1371/journal.pone.0007570.g003
SDF-1 Targets the Nucleolus
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allowing nucleolar localization mediated by the basic C-terminal
domain. Sdf-1c thus joins the expanding number of dual-function
proteins, among which intrakinesare the most prominent examples.
Chemokines form part of the complex cytokine network, and there
is growing evidence that some cytokines of the IL-1 and FGF
families have intracellular actions; for example IL-1a precursor
[27], IL-33 [28], ESkine Ccl27 [29] and parathyroid hormone [30].
However, all reported functions of chemokines are mediated
through binding to their membrane-bound, or occasionally soluble,
receptors, and no pathway has been described for intracellular
localization of chemokines. These findings are thus the first
indication that chemokines can exert functions through pathways
unrelated direct intercellular communication.
Nucleolar localization suggests novel, as yet undefined, autocrine
functions for Sdf-1c in cardiac cells. Given its structural and
functional distinction from the other protein products of the Sdf-1
gene, including Sdf-1c expressed in brain, we propose that the non-
secreted form of Sdf-1c expressed in cardiac tissue be renamed
Cardiac Derived Factor 1 (Cdf-1). The human and rat orthologs are
highly homologous, and a similar subcellular distribution can be
envisaged in the adult heart, where Sdf-1c is also expressed [13,14].
Our results show high expression of Sdf-1c mRNA in the heart
after birth and in adulthood. Previously reported in situ hybridiza-
tion analysis of Sdf-1, using probes common to all isoforms, detected
expression in the developing mouse heart [22] and in adulthood
[18].Similarly,Sdf-1knockoutmicegivenoinformationonisoform-
specific functions, since gene targeting of Sdf-1 affects all three
isoforms[8];nonetheless,embryosdeficientforSdf-1show defectsin
septum formation in the developing heart, and based on our qRT-
PCR data it seems likely that loss of Sdf-1c expression is involved in
this defect. Recently Franco et al [31] have studied by imunohis-
tochemistry and non quantitative RT-PCR the expression pattern
of Sdf-1 during mouse development with special attention to Sdf-1c.
The results of these authors are substantially different to our
quantitative data, particularly regarding expression in adult and
neonatal heart of Sdf-1c and Sdf-1b in the liver. A detailed
observation of their data shows defects in actin controls beside the
technique employed by those authors is not accepted as quantita-
tive. Importantly, our data support the idea that in cardiac tissue the
signal obtained by Franco et al in the heart with K15 antibody
correspond to isoform –a and –b as the region recognized by the
antibody K15C is encode in the N-terminal end of the protein ([31]
andreferences therein)that isskippedduringexpressionofSdf-1c in
the heart, as we describe in this paper.
The slmRNA appears to be the most abundant Sdf-1c transcript
expressed in the adult mouse heart, whereas brain expresses the
longer transcript, which includes the signal peptide sequence.
Although some minor expression of the slmRNA form might occur
in brain, our results suggest that Sdf-1c proteins in heart and brain
Figure 4. Expression of Sdf-c uses a non-canonical CUG
translation initiation codon. (A) Schematic representation of mRNA
species for Sdf-1c (slmRNA) compared with Sdf-1a/b isoforms. The
signal peptide is shown in orange and the specific 4
th exon of Sdf-1c is
in dark grey. The diagram below represents the SDF-1c-eGFP tagged
constructs containing CUG codons mutated (triangles). The nucleotide
sequence corresponds to the cDNA for Sdf-1c. The positions of the
mutated non-canonical CUG-initiation codons are in bold, and named
M2 to M4, and the mutation M1 of AUG common to Sdf-1a/b.( B) cDNA
synthesized from slmRNA obtained from cardiac tissue was cloned and
the resulting plasmid (pcDNA-Sdf1c-145-450) was transfected into
HEK293T cells. Expression of Sdf-1c was detected with specific anti-Sdf-
1c antibody (anti-c). Nuclei were stained with DAPI (blue). (C) Plasmids
encoding SDF-1c-eGFP tagged constructs mutated in each of the CUG
codons (M1 to M4) were transfected into HEK293T cells and the
expression Sdf-1c was monitored by eGFP fluorescence.
doi:10.1371/journal.pone.0007570.g004
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to their different fates and functions in each tissue. Further
experiments will be needed to determine the relevance and
functional implications of such differences.
In our experiments we examined Sdf-1c protein expression by
Western blot of transfected cloned cDNA derived from Sdf-1c
mRNA from brain. This mRNA species contains the exon encoding
the signal peptide, and gives rise to two specific bands of
approximately 14 and 12 KDa on polyacrylamide gels (Fig. 2E).
These apparent sizes are consistent with the translation of one
protein from the ATG codon (119 amino acids) and one from the
CUG codon starting at position 169 (93 amino acids) described in
this study. These data suggest either that ribosomes are able to
initiate translation from two different codons in the same mRNA or
that there are two mRNAs, the slmRNA and the larger species
containing the ATG codon. Further studies on the transcription and
translation of this gene in the brain are required to explore the
diversity and specificities of the regulation of the Sdf-1c gene.
ExpressionincardiactissueoftheshortSdf-1cwithnosignalpeptide
is consistent with the data obtained by Segret et al [18], showing that
in vivoin rat cardiac tissue, Sdf-1c is an intracellular 12 kDa protein.
Conflicts on the journey toward the cell nucleus
Sdf-1c contains an NLS/NoLS that we have mapped to the
exon-4-encoded C-terminal domain. The presence of a secretory
signal motif and a NLS in the same protein creates potential for
conflictive or complex regulation of protein fate. Signal peptides
direct proteins toward the endoplasmic reticulum, and several
studies have deciphered the pathways by which certain dual-
function cytokines and growth factors can re-enter the cell
complexed to internalized target receptors and are transported
to intracellular sites such as the nucleus (for a review, see [31]). In
other cases, protein distribution is determined by competition
between the signals for secretion and nuclear localization [32].
However, no receptor-mediated internalization mechanism has
been reported for proteins such as Sdf-1c that bind to seven
transmembrane domain G-protein coupled receptors [31].
Instead, our data indicate that expression of Sdf-1c in the heart
follows a novel nuclear localization strategy involving alternate
mRNA processing and translation initiation.
The viability of slmRNA is confirmed by translation of Sdf-1c
from cDNA cloned from heart tissue, and the mutational analysis
demonstratesthattranslationofthistranscriptisinitiatedfromcodon
CUG at position 26 (a/b aa numbering). CUG is the most common
alternative initiation codon in metazoans [25], and more than a
dozen mammalian genes have been reported to produce isoforms
from non-AUG codons [24]. The CUG codon itself is unlikely to
confer cardiac specificity, since translation from this codon is widely
observed in lymphoid [33], neuronal [34] and endothelial [35] cells.
The CUG initiation codon for cardiac expression of Sdf-1c is
downstream of the first in-frame AUG codon, a feature shared only
with the alternative translation initiation of osteopontin (Opn) [33].
However,inthecaseofSdf-1cCUGusageappearstobedetermined
by a transcriptional control mechanism, rather than mRNA
secondary structure as in the case of Opn.
It is not clear by what mechanism the short Sdf-1c mRNA is
specifically synthesized in cardiac cells. There may be a specific
mechanism for transcription initiation that omits the signal peptide
sequence, or this sequence might be eliminated by the action of an
RNA exonuclease. Without the signal peptide sequence, the
slmRNA has a first exon shorter than any reported [36], which
raises questions about how such a short oligonucleotide sequence
can be spliced to the second exon. Whatever the mechanism, it will
be of interest to determine how this process is triggered exclusively
in the heart, and whether similar processes occur in other tissues
and with other cytokines.
Nucleolar localization signals are thought to interact with
structural nucleolar proteins or RNAs, but no consensus sequence
requirement has been identified for such signals beyond a
grouping of basic residues [37]. Our findings suggest that proper
nucleolar localization of Sdf-1c requires the whole set of basic
residues present in the C-terminal domain, arranged as four
clusters. We therefore propose the sequence KKEKIGKKK-
RQKKRKAAQKRK as a novel NoLS present in Sdf-1c.
The nucleolus is the most prominent subnuclear structure, and is
involved in ribosome subunit assembly. The accumulated data
suggest that the nucleolus contains a dynamic proteome of more
than 400 proteins and associates transcription regulatory networks
via several mechanisms [21], including degradation pathways
mediated by the ubiquitin–proteasome system operating in the
nucleus (nUPS) and nucleolar-cytoplasm or nucleolar-nucleoplasm
protein transit. Based on this last activity, the nucleolus can be
regarded as a reservoir of regulatory proteins, acting as a
sequestering compartment for regulatory complexes, or regulating
the exposure of proteins to proteolysis during developmental
decision-making (Hand 1) [38], hypoxia sensing responses (VHL)
[39], cell death and proliferation (AKT, p53, ARF, MDM2, c-myc)
and mitosis (Cdc14). Consistently, nucleolar targeting is associated
with regulatory mechanisms involved in cellular commitment, and,
intriguingly, during cardiac development [40]. Our results show
that nucleolar accumulation of Sdf-1c is unaffected by inhibition of
the nUPS, suggesting that nucleolar accumulation of Sdf-1c is
unrelated to protein quality-control [26,41]. It therefore appears
that Sdf-1c in the heart is localized to the nucleolus to exert its
biological function. Our preliminary data indicate that overexpres-
sion of Sdf-1c seems not to be required for the induction of
apoptosis or to promote any alteration of the cell cycle.
Concluding remarks
Organismal complexity relies partly on the capacity of genomes to
generate protein diversity. Such diversity is commonly achieved
through alternative gene expression pathways (alternative transcrip-
tional initiation, mRNA splicing and translation initiation), allowing
related proteins to acquire domains that confer novel activities [42].
Since the first description of intracellular forms of growth factors for
FGF family members and their receptors [reviewed in [43]], several
growth factors and cytokines have been shown to be expressed both
as secreted and intracellular forms (nuclear or cytoplasmic). By
including or deleting key domains from their structures, proteins can
be targeted to particular cell compartments and excluded from
others. Suchdiversity muststrikea balance between protein stability,
compatible signalling and multifunctionality.
We have shown that a product of the chemokine Sdf-1 gene is
specifically directed to the nucleolus through a combination of
transcriptional and translational mechanisms. The specific nucle-
olar expression of Sdf-1c in the heart suggests important functions
in this organ and provides the first example of a nucleolar directed
chemokine. These new properties of this isoform will lead to novel
insights into the functions encoded by the Sdf-1 gene.
Materials and Methods
Plasmid Construction
Plasmids were generated from PCR products with the pGEM-T
Easy system (Promega Biotech Ibe ´rica SL, Alcobendas, Spain). All
primers used are listed in Table S1. After sequencing, inserts were
excised by restriction digestion and subcloned in the HindIII site of
the destiny vector pmCerulean-C1 (Clontech, Saint-Germain-en-
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overexpression of proteins by either transfection or transduction,
inserts were subcloned in the XbaI site of pLV series lentiviral
vectors, derived from the HIV-based pRRsyn18 vector. All vectors
were verified by sequencing with an ABIPrism 3000 sequencer. The
final constructs are shown in Fig. S1. Plasmids harboring mutated
versions of the basic-residue clusters of the C-terminal region of Sdf-
1c were synthesised by DNA2.0 (Basel, Switzerland) and subcloned
into HindIII and XbaI restriction sites of pmCerulean-C1.
Mammalian Cell Culture and Transfection
The human embryonic kidney cell line HEK293T and the
Chinese hamster ovary (CHO) cell line were cultured under
standard conditions in DMEM (Cambrex) supplemented with 1%
Glutamax (Invitrogen, Prat del Llobregat, Barcelona, Spain),
10 mg/ml antibiotics (penicillin streptomycin) and 10% foetal
bovine serum (BioWhitaker). Cells were transfected with endotoxin-
free DNA (Qiagen, Las Matas, Madrid, Spain) and transfections
were carried out in 6-well plates unless otherwise stated. HEK293T
cells were transfected by the calcium-phosphate method, and CHO
cells were transfected using Lipofectamine 2000 (Invitrogen, Prat
del Llobregat, Barcelona, Spain). For proteasome inhibition
experiments, HEK293T cells were grown in 6-well plates, and
incubatedfor 8 h in the presence of 10 mMcarbobenzoxy-L leucyl-
L-leucyl-L-leucinal (MG132, Calbiochem, Nottingham, UK) dilut-
ed in DMSO (Sigma Aldrich, Alcobendas, Spain). Untreated and
DMSO treated cells were cultured in parallel as controls.
Mouse samples
Mice of the inbred strain C57BL/6 were purchased from the
Jackson Laboratory (Bar Harbor, Maine) and bred in our animal
facility under standard conditions. Female mice (8–12 weeks old)
were checked daily for pregnancy, and were anesthetised at the
indicated times and embryos removed aseptically. Embryonic
heart, bone marrow, liver, brain, yolk sac and AGM were
extracted, and tissues from 5–8 dams per time point were pooled
and used for RNA extraction. Adult tissues were extracted from
euthanized animals and individual samples were collected and
used for total RNA isolation.
Animals were housed in accordance with Spanish law for the
protection of animals used for experimental and other scientific
purposes, Real Decreto 1201/2005, which enacts EU Directive
86/609/EEC. Housing and husbandry conditions conform to the
Council of Europe Commission Recommendation of 18 June 2007
on guidelines for the accommodation and care of animals used for
experimental and other scientific purposes. The CNIC Ethical
Review Committee approved all animal procedures.
Antibodies
A rabbit polyclonal antiserum (anti-c) was raised against the
peptide KVGKKEKIGKKKRQ, mapping to the specific C-
terminal region of Sdf-1c (see Fig. S2). The N-terminal cysteine
enables direct conjugation of the peptide to the protein carrier and
is not present in the native sequence. Peptide synthesis, coupling,
immunization, ELISA titration and affinity purification were done
by BioGenes GmbH (Berlin, Germany).
Commercial antibodies used were mouse monoclonal anti pan-
Sdf-1 clone 79018.111 (R&D System, Abingdon, UK), rabbit anti-
fibrillarin - nucleolar marker (ab5821) (AbCam, Cambridge, UK),
goat anti mouse Troponin T (AbCam,), rabbit anti-mouse CD31
(Sigma Aldrich) and mouse anti V5 antibody (Molecular Probes,
Invitrogen). Secondary antibodies used were Alexa-488-conjugat-
ed goat anti-rabbit, Alexa-488-conjugated goat anti-mouse, Alexa-
633-conjugated goat anti-rabbit and Alexa-633-conjugated goat
anti-mouse (Molecular Probes, Invitrogen).
Confocal immunofluorescence and
immunohistochemistry
For subcellular localization of antigens by double-label indirect
immunofluorescence (IF), cells were seeded onto glass coverslips
coated with poly-L-Lysine (Sigma), transfected or transduced. 24
to 48 hours later, cells were washed twice with PBS and fixed
(5 min) in cold 4% paraformaldehyde, permeabilized with 0.5%
TritonX-100/PBS and blocked with 4% normal goat serum.
Thereafter samples were incubated (45 min, 37uC) with anti-c (1/
100 dilution), MAB350 (1/200) or anti-fibrillarin antibody (1/xxx).
Primary antibodies were diluted in PBS supplemented with 5%
goat serum.
The secondary antibodies Alexa-633-conjugated goat anti-rabbit
or Alexa-633-conjugated goat anti-mouse (Molecular Probes) were
used at 1/500. Finally, samples were dyed with ToPro3 or DAPI
(Invitrogen) to stain DNA, air dried and mounted in Gelatin (Sigma
Aldrich). Samples were examined with a Leica SP4 confocal laser
scanning microscope (Leica Microsystems Holdings, Wetzlar
Germany) fitted with two lasers giving excitation at 488 nm and
633 nm(for secondary antibodies)and 633 nm(ToPro3) or405 nm
(DAPI). Data were collected sequentially at a resolution of
102461024 pixels from 0.5–1.0 mm thick optical slices.
Immunohistochemistry was performed on OCT-preserved
mouse heart samples. Thin (5 mm) cryosections were fixed in 4%
paraformaldehyde. Antigens were retrieved by incubating samples
in citrate buffer for 30 min at 85uC. Sections were blocked in 5%
goat serum (Sigma Aldrich) and double labeled with anti-c serum
(1/100) or MAB350 (1/1000) together with anti troponin T
(AbCam: 1/200) or anti CD31 (Sigma Aldrich: 1/500). Antibodies
were diluted in PBS and incubations conducted overnight in a
humidified chamber at 4uC. Anti-mouse or anti-rabbit secondary
antibodies (Molecular Probes, Invitrogen) were diluted 1/500 in
PBS and incubations were conducted under similar conditions.
Sections were counterstained with DAPI and mounted with
Gelatin (Sigma Aldrich). Slides were examined with a Leica SP5
confocal microscope (Leica Microsystems Holdings).
RNA Extraction and qRT-PCR
Total RNA was extracted from tissues and cell cultures using
Trizol (Sigma Aldrich) according to the manufacturer’s procedure,
followed by a treatment with RNase-free DNase (Roche Applied
Science, Sant Cugat del Valle `s, Barcelona, Spain). Aseptically
removed organs were homogenized in extraction buffer with an
Ultra Turrax T8 mechanical homogenizer (Janke & Kunkel,
Staufen, Germany), and RNA was purified from cleared lysates.
cDNA was synthesized from 500 ng total RNA using a
Superscript III First Strand cDNA synthesis kit (Invitrogen).
Amounts of specific mRNAs in samples were quantified by qRT-
PCR using an ABIPrism 7900 HT Detection System (Applied
Biosystems, Foster City, CA, USA) and SYBER green detection.
PCR was performed in 96-well microtest plates (Applied
Biosystems) with 0.5 units of Taq Polymerase (Applied Biosystems)
per well and 35-40 cycles. In all experiments, mRNA amounts
were normalized to the total amount of cDNA by using
amplification signals for 18S and GAPDH. Each sample was
determined in triplicate, and at least three independent samples of
each tissue or cell line were analyzed. The efficiency of each
primer pair was measured using the Real-Time PCR MINER
software (http://miner.ewindup.info/miner/). Primer sequences
and PCR conditions are listed in Table S1.
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Two pairs of primers were used for first and nested amplifications.
59RACE was conducted with the SMART
TM RACE cDNA
amplification kit (Clontech), following the manufacturer’s instruc-
tions. Briefly, a first cDNA synthesis was performed with oligo dT
primers supplied by manufacturer, and dC residues were introduced
by the reverse transcriptase when it reached the mRNA end. These
cDNAs were then annealed to SMART II A oligonucleotides, which
serve as a template for subsequent PCR reactions in combination
with specific reverse primers. The primer sequences used for this
assay are detailed in Table S1. Specific primers targeted exon 4 and
common primers targeted exon 3. The products of nested PCR were
cloned into pGEM-T easy vector and sequence analyzed.
Western blot
Proteins were extracted following standard procedures in the
presence of Complete Protease Inhibitor Cocktail Tablets (Roche
Applied Science). Western blots were carried out by standard
methods on proteins transferred to PVDF using TransFi
(Invitrogen). Membranes were probed for Sdf-1 with MAB350
(1/1000) or anti-c serum (1/200) in PBS/0.1% Tween-20 (PBS-
Tween). Secondary antibodies were HRP-conjugated goat anti-
mouse IgG or goat anti-rabbit IgG (Santa Cruz Biotechnology,
Inc., Heidelberg, Germany), and blots were developed with ECL
(GE Healthcare, Alcobendas, Spain) as previously described [44].
Cell fractionation
Cytoplasm, nucleoplasm and nucleoli were purified as previ-
ously described [45]. Briefly, 80610
6 exponentially growing
HEK293T cells were scraped into cold TNMK buffer (50 mM
Tris-HCl, 130 mM NaCl, 5 mM KCl, 8 mM MgCl2, pH 7.2),
and a sample representing whole-cell extract was retained. Cells
were then pelleted and resuspended in RSB-5 hypotonic buffer
(10 mM Tris-HCl, 10 mM NaCl, 5 mM Mg acetate, pH 7.4),
allowed to swell on ice for 30 min, and lysed by the addition of
NP40 to a final concentration of 0.3%. After Dounce homoge-
nization, the nuclear fraction was recovered by low speed
centrifugation and the cytoplasmic supernatant was retained.
Nuclei were further purified by centrifugation through 0.88M
sucrose and resuspended in 0.34M sucrose plus 0.5 mM
magnesium acetate (sonication buffer), and were sonicated to
release the nucleoli. These were purified by two centrifugation
cycles through 0.88M sucrose: the supernatant of the first cycle is
the nucleoplasm fraction and the pellet of the second cycle
corresponds to the nucleolar fraction. Pellets were adjusted to
represent cell equivalent fractions of the starting material.
Supporting Information
Table S1 List of Primers used
Found at: doi:10.1371/journal.pone.0007570.s001 (0.05 MB
DOC)
Figure S1 (A) Genetic organization of mouse Cxcl12. Schematic
representation of annotated mRNA species for Sdf-1c and compared
that of Sdf-1a/b isoforms. Common exons to the three isoforms are
depicted by yellow boxes, the signal peptide in orange and the specific
4th exon of Sdf-1b or c in green or respectively. Numerals under the
exons indicate the residue numbers starting in the Met of a and b
isoforms. Numbers in the upper scale refers to nt starting in +1o fS d f -
1a/b mRNAs. (B) Schematic representation of the plasmids used
along this investigation containing the depicted mouse Cxcl12
cDNAs. Color are as in (A) and the specific 4th exon of Sdf-1c is
shown in black with coloured bars representing groups of basic (Lys
and Arg) residues (see Fig. 2A).
Found at: doi:10.1371/journal.pone.0007570.s002 (2.89 MB TIF)
Figure S2 (A) The sequence of the peptide used to raise the anti-c
antibody is indicated by a yellow box below the enlarged specific 4th
exonofSdf-1c. (B)Westernblot of HEK293T total cell extracts obtained
fron transfected cultures with the indicated plasmids expressing either
Sdf-1a/b or Sdf-1c and revealed with affinity purified anti-c serum (left)
or the commercial pan SDF-1 MAB350 antibody and were developed
with HRT-goat antirabbit or HRT-goat antimouse, respectively.
Found at: doi:10.1371/journal.pone.0007570.s003 (1.17 MB TIF)
Figure S3 Inhibition of proteosome protein-degradation with
MG132 has no effect on nucleolar accumulation of Sdf-1c.
HEk293T cells were transfected with pcDNA-Sdf1c-134-450
(Fig. 4B) and after 24 h the proteosome inhibitor MG132 was
added to the next 6 h. Asfterward cells were fixed and stained for
Sdf-1c with anti-c. Cells were treated with the olvent DMSO and
sowed as MOCK. Nuclei are staine in blue with DAPI.
Found at: doi:10.1371/journal.pone.0007570.s004 (6.89 MB TIF)
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